Aldeyra Therapeutics (NASDAQ:ALDX) is up 8.7% postmarket after a filing noting Joseph Edelman’s Perceptive Advisors raised its stake to 19.1%.
Perceptive acquired 3.2M shares at an average price of $4.25 on Thursday, according to a Form 4 filing.
That brought indirect beneficial ownership to 6,285,458 shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.